Two Sigma Securities »

Synthetic Biologics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Synthetic Biologics (TOVX) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Synthetic Biologics

Tip: Access up to 7 years of quarterly data

All positions including Synthetic Biologics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Synthetic Biologics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-03-31 $10k 21k 0.47
2023-09-30 $8.6k 16k 0.54
2022-09-30 $18k 18k 0.98

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Chevron Corporation (CVX)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Broadcom (AVGO)
Super Micro Computer Call Option (SMCI)
Eli Lilly & Co. Call Option (LLY)
Lockheed Martin Corporation Call Option (LMT)

View all positions for Two Sigma Securities

Top funds holding Synthetic Biologics

Vanguard Group
BlackRock
Geode Capital Management
Northern Trust
Citadel Advisors
Two Sigma Securities
Charles Schwab Investment Management
Lincoln National
SageView Advisory Group
William Blair $ Company
Iron Horse Wealth Management
IFP Advisors
Wells Fargo & Company
Tower Research Capital
Old Point Trust & Financial Services N A

View all funds holding Synthetic Biologics